RT Journal Article ID 58c5ac996d80e57a A1 Prabhu, Venugopal Vinod A1 Prabhu, Vinod T1 Regulating RNA Binding Motif 5 Gene Expression− A Novel Therapeutic Target for Lung Cancer JF Journal of Environmental Pathology, Toxicology and Oncology JO JEP(T) YR 2017 FD 2017-06-20 VO 36 IS 2 SP 99 OP 105 K1 RNA binding motif 5 K1 RBM5 K1 lung cancer K1 epidermal growth factor receptor K1 apoptosis K1 metastasis K1 targeted gene therapy AB RNA-binding motif protein 5 (RBM5), also known as LUCA-15/H37, is a gene that maps to human chromosome 3p21.3, a critical region that is deleted in a large number of human cancers, of which the majority are lung cancers, and that is predicted to contain one or more tumor suppressor genes (TSGs). RBM5 is a tumor suppressor gene and is most frequently deleted at the earliest stage of lung cancer development. It represents a significant area of recent progress in cancer genomic, cytogenetic, and molecular biological research because of its role in the induction of cell cycle arrest and apoptosis and the regulation of inhibition of in lung cancer metastasis. RBM5 is involved in the suppression of epidermal growth factor receptor (EGFR) expression, thus preventing proliferation, angiogenesis, invasion, and metastasis of lung cancer. In this way it exhibits its tumor suppressive capacity during lung cancer progression. Exploration of RBM5's potential importance in inhibiting tumor metastasis includes downstream players in the RBM5-mediated metastasis suppressor pathway(s). This review highlights the differential expression of the RBM5 tumor suppressor gene which impacts cell proliferation and apoptosis control during lung cancer progression. Regulating RBM5 expression may be a novel therapeutic target for lung cancer. PB Begell House LK https://www.dl.begellhouse.com/journals/0ff459a57a4c08d0,07051ad6449b2804,58c5ac996d80e57a.html